Recent Advances in Endocrine Disease and Atherosclerosis
A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Endocrinology and Metabolism Research".
Deadline for manuscript submissions: 31 March 2026 | Viewed by 476
Special Issue Editor
2. Nutrition Department, Hospital Clinico Universitario of Valencia, 46010 Valencia, Spain
3. INCLIVA Biomedical Research Institute, 46010 Valencia, Spain
4. CIBER de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III, 28029 Madrid, Spain
Interests: diabetes; dyslipidemia; insulin resistance; atherosclerosis; cardiovascular disease; inflammation
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Atherosclerosis is one of the leading causes of death in the world. Many factors have been associated with the development of atherosclerosis and cardiovascular disease. Different endocrine disorders, such as diabetes, dyslipidemia, obesity, acromegaly, Cushing’s syndrome, and hypothyroidism, have been associated with accelerated atherosclerosis and coronary artery disease.
This Special Issue of Biomedicines focuses on recent advances in the etiology, pathogenesis, diagnosis, and treatment of endocrine disorders related to atherosclerosis and cardiovascular disease development. Detailed knowledge on this topic is needed to prevent the development of cardiovascular disease.
Dr. Sergio Martínez-Hervás
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- diabetes
- dyslipidemia
- obesity
- insulin resistance
- subclinical atherosclerosis
- atherosclerosis
- cardiovascular disease
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
